Please login to the form below
trial data
This page shows the latest trial data news and features for those working in and with pharma, biotech and healthcare.
CanSinoBIO considers booster jab for COVID-19 vaccine
Tao added that a booster dose is being considered, with trial participants potentially set to receive a second jab around six months after their first dose. ... Tao. He said, however, that further clinical trial data is required before the exact efficacy
Latest news
-
J&J’s multiple sclerosis therapy Ponvory moves closer to EU approval
The EU marketing authorisation application for the S1P1 modulator is based on data from the phase 3 OPTIMUM trial, designed to evaluate the efficacy of once daily oral Ponvory versus
-
AZ publishes primary analysis for COVID-19 vaccine, showing slightly lower efficacy of 76%
AZ about the initial COVID-19 vaccine trial data. ... The concerns over the US trial data for AZ’s vaccine came following a safety review from the European Medicines Agency (EMA) over reports of blood clots in people who had
-
New data for Recordati’s Isturisa reinforces benefit in Cushing’s disease
Recordati Rare Disease has revealed new data from a phase 3 trial of its Cushing’s disease treatment Isturisa. ... Isturisa also met the key secondary endpoint of the LINC 4 trial, with 81% of patients having normal mUFC levels at week 36.
-
Efficacy data from US trial for AZ/Oxford vaccine raises concerns over possible 'incomplete view'
that it was ‘concerned’ over the initial COVID-19 vaccine trial data released yesterday. ... According to a statement from NIAID, the DSMB was concerned that AZ may have included outdated information from the trial, which could have provided an
-
CureVac expands COVID-19 vaccine trial protocol to include variant specification
Company is aiming to ensure its vaccine efficacy data is 'meaningful' against new virus variants. ... from our HERALD trial,” said Ulrike Gnad-Vogt, interim chief development officer of CureVac.
More from news
Approximately 45 fully matching, plus 769 partially matching documents found.
Latest Intelligence
-
A new era for UK-Japanese scientific research relations
These guidelines exist because, historically, some regions have had limited willingness to rely on foreign clinical data. ... Adopting these guidelines recognised procedures under which trial data gathered in one region could be used to fulfil regulatory
-
A cultural shift in clinical research
travel to investigative sites, as well as increased device integrations with consumer and medical data capture tools. ... Perennial encryption technology is used to protect the sensitive data being collected and shared with trial leaders.
-
Transforming clinical trial data into a long-term asset
Meanwhile, 65% of compliance, legal and regulatory professionals described their ability to access archived trial data as ‘extremely inadequate’ or ‘very inadequate’. ... Yet it seems that numerous archives of clinical trial data could be
-
Think fast, be different: succeeding at speed chess in 2021’s COVID-19 world
Take a typical head-to-head study, for example. Most often, trial data is shown as a standard bar chart comparing each product on the key endpoints. ... EBCs can take a leadership role reaching HCPs in new and better ways through data visualisation.
-
The search for effective drug treatments for COVID-19
However, the data from the Solidarity trial does not negate other study results – particularly from a trial designed with the strictest of scientific standards and rigorous data collection, as is the ... The data was peer-reviewed and published in NEJM.
More from intelligence
Approximately 0 fully matching, plus 66 partially matching documents found.
Latest appointments
-
Clinerion appoints new regional head
Bariş Erdoğan takes up new role at the clinical trial data firm. ... Swiss-based clinical trial data firm Clinerion has appointed Bariş Erdoğan as its new regional head in a role that focuses on the expansion of its activities in Eastern Europe, the
-
Sanofi CEO Viehbacher to head EFPIA
One of the most pressing matters for EFPIA is the seemingly inevitable trend towards transparency of trial data, and Viehbacher has already commented on the subject.
-
Eric Green named NIH's data science lead
Dr Eric Green, current director of the National Human Genome Research Institue (NHGRI), is to serve as the first associate director for data science at the US National Institutes for Health ... This project offers a data repository with demographics,
-
Almac appoints Charlie Morris as VP new products and services in clinical technologies division
According to the company, which provides services to the pharma industry, he will oversee the development of its IXRS technology to manage patients, supplies, and clinical trial data.
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
proportion of male participants made it easier to get a clean sample of data with no anomalies. ... And, where they’re already represented, the industry needs to ensure trial data is analysed by sex.
-
Real-world evidence: breaking boundaries in rare disease
As a result, life sciences companies are turning to novel methods of collecting clinical data and innovative trial design. ... To solve this challenge, life sciences companies are factoring in additional considerations when generating clinical data.
-
Mistrust in medical research: a patient perspective
They are asking: what are the ingredients? How many people participated in a trial? ... In the meeting, they provided a transparent view of the drug development process, including why it usually takes so long to conduct a trial, how is long-term safety
-
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
Applying machine learning to drive diagnostic algorithms within healthcare data sources to identify ‘at-risk’ patients. ... Leverage real-world data to identify patients and facilitate clinical trial recruitment.
-
New from the PhRMA: Diversity in clinical trials principles summarised
3.Using real-word data to enhance information on diverse populations beyond product approval. ... The policies should be specifically focused on enhancing diversity of clinical trial populations.
More from PMHub
Approximately 1 fully matching, plus 31 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Principal Medical Writer
-
Varies on experience
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
-
Account Management
-
Competitive Salary Offered
- Senior Content Editor - Biotechnology
-
Salary TBC
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Oxford University to investigate nasal spray delivery of AZ-partnered COVID-19 vaccine
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- New restrictions for AZ/Oxford COVID-19 vaccine despite EMA endorsement
- Moderna launches COVID-19 vaccine booster study to address new variants
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Roche, Regeneron’s COVID-19 antibody cocktail cuts infection risk
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Change for good: the virtual congress audience is too big to be ignored
- 3 tips to show patient diversity in your clinical trial materials
- Live Webinar: Nanobiotechnology, Artificial Intelligence, and Virtual Care
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- 3 tips to show patient diversity in your clinical trial materials
- Here are some useful tips to help get your hands on authentically diverse stock photos....
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
- When Will We Be Back To Normal?
- The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
Quick links
Infographics
